News

Filter

Current filters:

FabrazymeBiotechnology

1 to 9 of 18 results

Genzyme to start shipping Fabrazyme from newly-approved plant

01-03-2012

French drug major Sanofi's (Euronext: SAN) US subsidiary Genzyme says that it has begun shipping its…

BiotechnologyFabrazymeGenzymeMarkets & MarketingPharmaceuticalRare diseasesSanofi

Genzyme Framingham plant now cleared by US and EU regulators

24-01-2012

French drug major Sanofi (Euronext: SAN) said yesterday that the US Food and Drug Administration has…

BiotechnologyFabrazymeGenzymePharmaceuticalRare diseasesRegulationSanofi

Ongoing supply problems for Genzyme’s Cerezyme

19-09-2011

US biotech Genzyme, now a subsidiary of French drug major Sanofi (Euronext: SAN), says it will have only…

BiotechnologyCerezymeFabrazymeGenzymeMarkets & MarketingPharmaceuticalRare diseasesSanofiShire

Genzyme’s 2nd-qtr 2010 profits plunge on continuing Cerezyme and Fabrazyme supply problems

22-07-2010

Troubled US biotechnology firm Genzyme yesterday revealed that net profit for the second quarter of 2010…

BiotechnologyCerezymeFabrazymeFinancialGenzymePharmaceutical

Further supply disruption of Genzyme's Cerezyme and Fabrazyme leads EMEA to give new temporary treatment recommendations; but no problems with Myozyme

23-04-2010

Troubled US biotech firm Genzyme has advised the European Union health regulator that the supply shortages…

BiotechnologyCerezymeEuropeFabrazymeGenzymeMyozymeRare diseasesRegulation

1 to 9 of 18 results

COMPANY SPOTLIGHT

Menarini

Back to top